Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8369)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2015 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Wu IT, Chuah SK, Lee CH, Liang CM, Lu LS, Kuo YH, Yen YH, Hu ML, Chou YP, Yang SC, Kuo CM, Kuo CH, Chien CC, Chiang YS, Chiou SS, Hu TH, Tai WC. Five-year sequential changes in secondary antibiotic resistance of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i37/10669.htm |
| Number | Citing Articles |
| 1 |
Azucena Arévalo, William Alberto Otero, Alba Alicia Trespalacios. Helicobacter pylori: resistencia múltiple en pacientes de Bogotá, Colombia. Biomédica 2019; 39: 125 doi: 10.7705/biomedica.v39i3.4437
|
| 2 |
Alessia Savoldi, Elena Carrara, David Y. Graham, Michela Conti, Evelina Tacconelli. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology 2018; 155(5): 1372 doi: 10.1053/j.gastro.2018.07.007
|
| 3 |
Tzung‐Shiun Wu, Ping‐I Hsu, Chao‐Hung Kuo, Huang‐Ming Hu, I‐Chen Wu, Sophie S.W. Wang, Yen‐Hsu Chen, Deng‐Chyang Wu, Wei‐Wen Su, Fu‐Chen Kuo. Comparison of 10‐day levofloxacin bismuth‐based quadruple therapy and levofloxacin‐based triple therapy for Helicobacter pylori. Journal of Digestive Diseases 2017; 18(9): 537 doi: 10.1111/1751-2980.12498
|
| 4 |
Min Ho Lee, Ji Yeong Yang, Yoonjung Cho, Hyun Jun Woo, Hye Jin Kwon, Do Hyun Kim, Min Park, Cheol Moon, Min Ji Yeon, Hyun Woo Kim, Woo-Duck Seo, Sa-Hyun Kim, Jong-Bae Kim. Inhibitory Effects of Menadione on Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation via NF-κB Inhibition. International Journal of Molecular Sciences 2019; 20(5): 1169 doi: 10.3390/ijms20051169
|
| 5 |
Ji Yeong Yang, Jong-Bae Kim, Pyeongjae Lee, Sa-Hyun Kim. Evodiamine Inhibits Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation. International Journal of Molecular Sciences 2021; 22(7): 3385 doi: 10.3390/ijms22073385
|
| 6 |
Mohammad Sholeh, Saeed Khoshnood, Taher Azimi, Jasem Mohamadi, Vahab Hassan Kaviar, Marzieh Hashemian, Somayeh Karamollahi, Nourkhoda Sadeghifard, Hedayat Heidarizadeh, Mohsen Heidary, Morteza Saki. The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis. PeerJ 2023; 11: e15121 doi: 10.7717/peerj.15121
|
| 7 |
Joseph Opeolu Ashaolu, Yu-Jen Tsai, Chia-Chen Liu, Dar-Der Ji. Prevalence, diversity and public health implications of Helicobacter species in pet and stray dogs. One Health 2022; 15: 100430 doi: 10.1016/j.onehlt.2022.100430
|
| 8 |
Te-Fu Lin, Ping-I Hsu. Second-line rescue treatment of <i>Helicobacter pylori</i> infection: Where are we now?. World Journal of Gastroenterology 2018; 24(40): 4548-4553 doi: 10.3748/wjg.v24.i40.4548
|
| 9 |
UEG Week 2018 Poster Presentations. United European Gastroenterology Journal 2018; 6(S8) doi: 10.1177/2050640618792819
|
| 10 |
Margarita Camorlinga-Ponce, Alejandro Gómez-Delgado, Emmanuel Aguilar-Zamora, Roberto C. Torres, Silvia Giono-Cerezo, Antonio Escobar-Ogaz, Javier Torres. Phenotypic and Genotypic Antibiotic Resistance Patterns in Helicobacter pylori Strains From Ethnically Diverse Population in México. Frontiers in Cellular and Infection Microbiology 2021; 10 doi: 10.3389/fcimb.2020.539115
|
| 11 |
Ping‐I Hsu, Feng‐Woei Tsay, John Y. Kao, Nan‐Jing Peng, Yan‐Hua Chen, Sheng‐Yeh Tang, Chao‐Hung Kuo, Sung‐Shuo Kao, Huay‐Min Wang, I‐Ting Wu, Chang‐Bih Shie, Seng‐Kee Chuah, Deng‐Chyang Wu. Tetracycline‐levofloxacin versus amoxicillin‐levofloxacin quadruple therapies in the second‐line treatment of Helicobacter pylori infection. Helicobacter 2021; 26(5) doi: 10.1111/hel.12840
|
| 12 |
Jennifer Li, Xian-Zhi Li. Efflux-Mediated Antimicrobial Resistance in Bacteria. 2016; : 489 doi: 10.1007/978-3-319-39658-3_19
|
| 13 |
Chih-Ming Liang, Wei-Chen Tai, Pin-I Hsu, Deng-Chyang Wu, Chao-Hung Kuo, Feng-Woey Tsay, Chia-Long Lee, Kuan-Yang Chen, Seng-Kee Chuah. Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from Taiwan. Therapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284820976990
|
| 14 |
Ping-I Hsu, Feng-Woei Tsai, Sung-Shuo Kao, Wen-Hung Hsu, Jin-Shiung Cheng, Nan-Jing Peng, Kuo-Wang Tsai, Huang-Ming Hu, Yao-Kuang Wang, Seng-Kee Chuah, Angela Chen, Deng-Chyang Wu. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial. American Journal of Gastroenterology 2017; 112(9): 1374 doi: 10.1038/ajg.2017.195
|
| 15 |
Hye Jin Kwon, Min Ho Lee, Hyun Woo Kim, Ji Yeong Yang, Hyun Jun Woo, Min Park, Cheol Moon, Sa-Hyun Kim, Jong-Bae Kim. Riboflavin Inhibits Growth of Helicobacter pylori by Down-regulation of polA and dnaB Genes. Biomedical Science Letters 2020; 26(4): 288 doi: 10.15616/BSL.2020.26.4.288
|
| 16 |
Sudhansubala Lenka, Ruchi Bhuyan. Management of H. pylori Induced Peptic ulcer – A Phytotherapeutic Approach. Journal of Pure and Applied Microbiology 2022; 16(3): 1530 doi: 10.22207/JPAM.16.3.36
|
| 17 |
Seng-Kee Chuah, Chih-Ming Liang, Chen-Hsiang Lee, Shue-Shian Chiou, Yi-Chun Chiu, Ming-Luen Hu, Keng-Liang Wu, Lung-Sheng Lu, Yeh-Pin Chou, Kuo-Chin Chang, Chung-Huang Kuo, Chung-Mou Kuo, Tsung-Hui Hu, Wei-Chen Tai. A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication. Medicine 2016; 95(19): e3586 doi: 10.1097/MD.0000000000003586
|
| 18 |
Reza Khashei, Mahintaj Dara, Abdollah Bazargani, Kamran Bagheri Lankarani, Alireza Taghavi, Maryam Moeini, Behzad Dehghani, Maryam Sohrabi. High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolates. APMIS 2016; 124(9): 787 doi: 10.1111/apm.12567
|
| 19 |
Lien-Chieh Lin, Tzu-Herng Hsu, Kuang-Wei Huang, Ka-Wai Tam. Nonbismuth concomitant quadruple therapy for <i>Helicobacter pylori</i> eradication in Chinese regions: A meta-analysis of randomized controlled trials. World Journal of Gastroenterology 2016; 22(23): 5445-5453 doi: 10.3748/wjg.v22.i23.5445
|
| 20 |
Xiao-Feng Luo, Jian-Hua Jiao, Wen-Yue Zhang, Han-Ming Pu, Bao-Jin Qu, Bing-Ya Yang, Min Hou, Min-Jun Ji. Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of <i>Helicobacter pylori</i>. World Journal of Gastroenterology 2016; 22(25): 5822-5830 doi: 10.3748/wjg.v22.i25.5822
|
| 21 |
Chih-An Shih, Chang-Bih Shie, Wei-Chen Tai, Seng-Kee Chuah, Hsi-Chang Lee, Ping-I Hsu. Update on the second-line treatment of Helicobacter pylori infection: a narrative review. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231192750
|
| 22 |
Xuan-Di Cao, Ya-Ling Huang, Jung-Sheng Chen, Chien-Sen Liao. Molecular surveillance of Helicobacter species with high prevalence from two streams with various wastewater pollution in Taiwan. One Health 2024; 18: 100757 doi: 10.1016/j.onehlt.2024.100757
|
| 23 |
Agnes Tving Stauning, Rie Louise Møller Nordestgaard, Tove Havnhøj Frandsen, Leif Percival Andersen. Helicobacter pylori [Working Title]. 2018; doi: 10.5772/intechopen.80662
|
| 24 |
Chao Ran Ji, Jing Liu, Yue Yue Li, Chen Qiao, Jun Yan Qu, Jun Nan Hu, Min Juan Lin, Rui Ji, Li Xiang Li, Xiu Li Zuo, Yan Qing Li. Susceptibility‐guided quadruple therapy is not superior to medication history‐guided therapy for the rescue treatment of Helicobacter pylori infection: A randomized controlled trial. Journal of Digestive Diseases 2020; 21(10): 549 doi: 10.1111/1751-2980.12934
|
| 25 |
Jiunn‐Wei Wang, Ping‐I Hsu, Ming‐Hong Lin, John Kao, Feng‐Woei Tsay, I‐Ting Wu, Chang‐Bih Shie, Deng‐Chyang Wu. The efficacy of culture‐guided versus empirical therapy with high‐dose proton pump inhibitor as third‐line treatment of Helicobacter pylori infection: A real‐world clinical experience. Journal of Gastroenterology and Hepatology 2022; 37(10): 1928 doi: 10.1111/jgh.15942
|